REDEFINING THEFUTURE OF CAR T LEARN ABOUT OUR SCIENCE Allogene Therapeutics is a clinical-stage biotechnology company with a single-minded focus on pioneering the development of investigational allogeneic chimeric antigen receptor…

REDEFINING THEFUTURE OF CAR T LEARN ABOUT OUR SCIENCE Allogene Therapeutics is a clinical-stage biotechnology company with a single-minded focus on pioneering the development of investigational allogeneic chimeric antigen receptor…

PIPELINE LEARN ABOUT AlloCAR T™ PRODUCTS OUR AlloCAR T™ PRODUCT PIPELINE TARGETS A VAST ARRAY OF TUMOR TYPES AND AUTOIMMUNE INDICATIONS ¹Phase 2 designed to be registrational ²ALLO-647 (anti-CD52 mAb) is…

PIPELINE LEARN ABOUT AlloCAR T™ PRODUCTS OUR AlloCAR T™ PRODUCT PIPELINE TARGETS A VAST ARRAY OF TUMOR TYPES AND AUTOIMMUNE INDICATIONS ¹Phase 2 designed to be registrational ²ALLO-647 (anti-CD52 mAb) is…

OUR CULTURE Environmental, Social AND Governance (ESG) REPORT At Allogene, our culture embraces being good to one another, taking ownership, and aiming for excellence in everything we do. These principles…

OUR CULTURE Environmental, Social AND Governance (ESG) REPORT At Allogene, our culture embraces being good to one another, taking ownership, and aiming for excellence in everything we do. These principles…

TERMS OF USE Effective February 1st 2023. LEGAL DISCLAIMERS This web site, and the documents contained in (or directly accessible from) this web site, include forward-looking statements within the meaning…

PRIVACY NOTICE THIS PRIVACY NOTICE WAS LAST UPDATED ON FEBRUARY 1st 2023. Allogene Therapeutics ("Allogene", "we", "us" and/or "our") respects your privacy and we want you to be familiar with…